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S U M M A R Y
Objectives: To evaluate the presence of human T-lymphotropic virus type 1 (HTLV-1) infection in isolated
rural communities in the southern Andes of Peru.
Methods: We conducted a cross-sectional study in ﬁve communities located in three provinces in
Ayacucho, Peru. The ﬁve communities are located at >3000 meters above sea level and are mainly rural,
and more than 85% of the population speaks Quechua. Volunteers aged 12 years and older were included.
Clinical and epidemiological data were collected, along with a blood sample for serological testing.
Results: We included 397 participants; their median age was 41 years (interquartile range 31–57 years)
and 69% were women. According to our deﬁnitions, 98% were of Quechua origin. HTLV-1 was diagnosed
in 11 people: 0/164 in Cangallo, 3/154 (2%) in Vilcashuaman, and 8/79 (10%) in Parinacochas. There were
no cases of HTLV-2. All the HTLV-1-positive participants were born in Ayacucho and were of Quechua
origin; they ranged in age from 29 to 87 years (median 56 years) and 10/11 were women. Ten were
apparently healthy, and one woman was diagnosed with HTLV-1-associated myelopathy/tropical spastic
paraparesis (HAM/TSP). Three out of 11 had a family member with a lower limb impairment compatible
with HAM/TSP.
Conclusion: The fact that HTLV-1 infection was present in two out of three provinces suggests that HTLV-
1 could be highly endemic in the southern Andes in the Quechua population.
 2013 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. 
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Human T-cell lymphotropic virus type 1 (HTLV-1) is the
causative agent of adult T-cell lymphoma/leukemia (ATLL),
HTLV-1-associated myelopathy/tropical spastic paraparesis
(HAM/TSP), and HTLV-1-associated uveitis, and it increases
the risk of several other inﬂammatory and infectious diseases.1
The virus can be transmitted through blood transfusions or
shared needles, through sexual contact, and from mother to* Corresponding author. Current address: 11 Stuyvesant Oval, Apt 1-H, New York,
NY 10009, USA. Tel.: +1 202 621 3041.
E-mail address: fanny.ita.nagy@gmail.com (F. Ita).
1201-9712  2013 The Authors. Published by Elsevier Ltd on behalf of International So
http://dx.doi.org/10.1016/j.ijid.2013.10.005child mainly through breastfeeding.2 There is no treatment to
cure the infection or a satisfactory treatment for ATLL and
HAM/TSP, the two more severe consequences of HTLV-1
infection. However, there are prevention strategies that have
proven to decrease the prevalence in a population, such as
blood bank screening and avoiding breastfeeding from infected
mothers.3
HTLV-1 is clustered among different population groups around
the world: in Japan, the Caribbean basin, Central Africa, parts of
Melanesia, and in Amerindians of Central and South America. The
Quechuas are the major Amerindian ethnic group in Hispanic
South America.2,4–6 They are spread across the continent through
the Andes highlands and the majority live in Peru and Bolivia. In
Peru, they represent 13% of the total population;7 in Bolivia, 30%.8
There are many HTLV-1 prevalence studies in different indigenous
groups in South America, but only a few reports in Quechuas from
Peru9–11 and Bolivia.4,12ciety for Infectious Diseases. Open access under CC BY-NC-SA license.
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the prevalence of HTLV-1 infection. However there is strong
evidence suggesting that HTLV-1 is frequent and could affect 1–2%
of the total population. A study conducted among 528 healthy
women of three cities in Peru, reported an overall HTLV-1
prevalence of 2.5%.10 In the largest study done in Peru among
pregnant women, the authors found a prevalence of 1.7% at the
largest maternity hospital in Lima.13 Recently, a study in blood
banks in Arequipa, a city in the southern Andes of Peru, showed a
prevalence of HTLV-1 infection of 0.9%.14
Since 1991, a cohort of people living with HTLV-1 has been
followed by the Institute of Tropical Medicine ‘‘Alexander von
Humboldt’’ in Lima, Peru. By March 2007, this cohort included
1452 Peruvians with HTLV-1 infection, of whom 749 (51.5%) were
born outside Lima.15 Among the latter, the South Andean regions,
which are mainly inhabited by Quechua and Aymara people, stand
out because of the high number of persons infected. Also, Lima and
the central and southern Andes account for most of the cases with
HAM/TSP in the cohort. This observation was also described in a
case series of 61 patients with HAM/TSP done in Lima, where more
than 50% of the patients were born in an Andean region.16,17 Of
note, data from the 1993 National Census18 indicated that the
highest rate of lower-limb disability, which can be observed in
HAM/TSP cases, occurred in the southern Andean regions of Peru,
and, as also described for HAM/TSP, was more frequent in women
than in men.
Because of the scarce information on HTLV-1 prevalence in
Quechua populations and the indirect evidence suggesting a
signiﬁcant presence of HTLV-1 in the southern Andes of Peru, we
explored the infection frequency and risk factors among people of
this ethnic group living in the area and hypothesized that the
HTLV-1 frequency is above the values reported for other Peruvian
populations.
2. Materials and methods
2.1. Location
The study was focused on Ayacucho because this region is one
of the predominant birth places among the participants of the
HTLV-1 cohort at the Institute of Tropical Medicine ‘‘Alexander von
Humboldt’’.
Based on data from the National Census of 1993 – the last
survey in which disability of the lower limbs was recorded – we
selected the three provinces with the highest rates of lower-limb
disability that was not related to polio (data also provided by the
census): Cangallo, Vilcashuaman, and Parinacochas. We used the
same criteria to choose the ﬁve study towns from these provinces
(Figure 1, Table 1). We contacted the local health centers and
provided them with information about our study prior to
commencing work in those towns that were willing to collaborate
with the researchers.
Ayacucho is a mainly mountainous region in the south of Peru.
The ﬁve towns we visited are located between 3200 and 3500
meters above sea level. The weather is cold and dry, with
temperatures ranging between 15 and 20 8C during the day and
close to 0 8C during the night. The rainy season is from December to
March. According to the National Institute of Statistics, 80% of the
population is considered poor and 30% live in conditions of
extreme poverty.7 Forty-two percent of the population live in rural
areas, and there is an illiteracy rate of 17.9% among inhabitants
aged 15 years and older, much higher than the national average of
7.1%. Sixty-three percent of the population in this region speaks
Quechua. Ayacucho can be divided into three parts: the northern
part, which is the most developed one, with a good road network
that connects it with larger cities, including Lima; the central part,more isolated but still connected to the northern part and the
capital of the region; and the southern part, which is the least
densely populated area, with a separated road system and poor
communication with the other parts of Ayacucho (Table 1,
Figure 1).
2.2. Study population
We recruited volunteers aged 12 years and older. Since no
previous data were available regarding the number of people
affected, and because the remoteness of the communities
precluded random sampling, we chose arbitrarily to study 5–
10% of the population, approximately 400 participants in total.
Volunteers were included until this number was reached.
2.3. Laboratory testing
We collected 6 ml of blood from each participant, separated the
plasma by centrifugation, and stored it in cryovials. These samples
were frozen and transported to Lima. For each sample, other than
in one case, we performed two ELISAs.19 In that one sample,
insufﬁcient for additional tests, we performed an ELISA just once.
We used two commercial ELISA kits: Murex1 HTLVI+II (Murex
Biotech Ltd, Dartford, UK) and Ortho1 HTLV-I/HTLV/-II Ab-capture
ELISA test system (Ortho Clinical Diagnostic, Amersham, UK). The
two different brands of ELISA were used for each sample until
restrictions with the local availability of Ortho determined that we
performed the Murex test twice.
If at least one of the ELISA tests had a positive result, we
performed a conﬁrmatory test either with INNO-LIA1 HTLV-I/II
Score (Innogenetics, Ghent, Belgium) or Western blot HTLV Blot
2.41 (MP Diagnostics, Singapore). Whenever performed, the result
of the conﬁrmatory testing, carried out in accordance with the
manufacturer’s speciﬁcations, deﬁned the ﬁnal HTLV-1 status
category of the participant; there were four possible categories:
HTLV-1-positive, HTLV-2-positive, HTLV-indeterminate, and
HTLV-negative. All cases that had consistent negative results on
the ELISA tests, and thus did not require conﬁrmatory testing, were
also classiﬁed as HTLV-negative.
2.4. Data collection
The questionnaire was ﬁlled out by a health worker during a
face-to-face interview. We asked questions about the participant’s
demographics, risk factors for HTLV-1, diagnosed HTLV-1 compli-
cations, and symptoms potentially indicative of a complication.
Ethnicity was deﬁned according to the parents’ place of birth and
parents’ mother tongue. People were classiﬁed as Quechua if both
parents were born in an Andean region and both of them spoke
Quechua. If at least one parent did not fulﬁll both of these criteria,
the participant was considered mestizo. We explored risky sexual
behaviors and looked for risk factors for acquiring infection
through blood and syringes, such as transfusion and surgery
history. We gathered information regarding breastfeeding prac-
tices: how long people were breastfed and how long women
breastfed their infants. We included questions about surrogate
breastfeeding practices. We asked for symptoms and diseases that
could be related to HTLV-1 infection, such as ATLL, HAM/TSP,
infective dermatitis, strongyloidiasis, crusted scabies, and tuber-
culosis. We actively searched for HAM/TSP symptoms and
screened patients for trouble walking, trouble getting up from a
chair, and urinary incontinence. If HAM/TSP symptoms were
found, a detailed physical examination was done. The diagnosis of
HAM/TSP was made using the diagnostic criteria proposed by De
Castro-Costa et al.20 We also enquired about HAM/TSP-like
symptoms in direct relatives.
Figure 1. Map of Ayacucho region, provinces, and study locations.
F. Ita et al. / International Journal of Infectious Diseases 19 (2014) 46–52482.5. Statistical analysis
Chi-square, Mann–Whitney, and Kruskal–Wallis tests were
used to compare the characteristics of the participants from
different provinces and to compare the people with and without
HTLV-1 infection. The statistical package used for the analysis was
STATA version 10 (Stata Corp., College Station, TX, USA).
2.6. Ethical aspects
This study was conducted in accordance with the principles of
the Declaration of Helsinki. The Ethics Committee of theUniversidad Peruana Cayetano Heredia and the Ayacucho’s
Regional Department of Health reviewed and approved the project.
The informed consent document was translated into Quechua by a
professor of linguistics. The text was revised by health workers
whose ﬁrst language is Quechua. Each study participant chose
whether they wanted to go through the informed consent process
in Spanish or Quechua. One of the ﬁeld investigators was from the
area and was a native speaker of Quechua and he explained the
study to the Quechua speakers.
Because of a high rate of analphabetism, oral informed consent
was also used. This consent required the signature of a witness and
the ﬁngerprint of the participant. The investigator explained the
Table 1
Socio-demographic characteristics of the studied populations
Province District % Rural
populationa
% Illiteracya % Quechua
speakersb,c
% Povertyd % Extreme
povertyd
Study
towns
Accessibility Populationd Study
participants
(population %)
Road type/travel
time in hourse
Public
transportation
frequency
Parinacochas District a 35.4 18.3 85.4 76.1 36.7 Town A Unpaved road/2 h 2/week 375 28 (8%)
Town B Unpaved road/3 h 2/week 255 14 (5%)
District b 92.8 19.4 91.6 80.8 29.5 Town C Unpaved road/5 h 3/week 348 37 (10%)
Vilcashuaman District c 67.7 17 93.1 82.1 31.4 Town D Unpaved road Multiple times
a day
2927 154 (5%)
Cangallo District d 77 16.1 93.3 82.5 36.7 Town E Paved road and
small portion
unpaved road/3 h
Multiple times
a day
2239 164 (7%)
INEI, National Institute of Statistics.
a 2005 INEI Census.
b 1993 INEI Census.
c People who learned Quechua during childhood.
d 2007 INEI Census.
e Travel time from the Province Capital.
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Spanish or Quechua. After the explanation, the participant was
asked to repeat the main points of the study to ensure that they had
understood it. Each participant kept a copy of the informed consent
form, which included an explanation of the study and an
explanation of HTLV-1 infection. For participants younger than
18 years of age, we requested his/her authorization and the
authorization of one of the parents.
All volunteers were counseled before the test. Participants with
HTLV-1 infection also received post-test counseling to explain the
consequences of the infection. We offered medical attention at the
Institute of Tropical Medicine ‘‘Alexander von Humboldt’’ for those
participants with HTLV-1. Local health workers were informed
about HTLV-1 infection and its consequences, and were trained in
the management and monitoring of the patients with the infection.
In this way, we ensured that people diagnosed with HTLV-1
infection could approach their local center as well.
3. Results
We recruited 397 participants from three provinces: 154 from
Vilcashuaman, 164 from Cangallo, and 79 from Parinacochas. We
recruited participants from one town in Vilcashuaman, one town in
Cangallo, and three towns in Parinacochas. Some of the character-
istics of the participants are shown in Table 2. The median age was
different among provinces (Kruskal–Wallis, p < 0.001). Three
hundred and ninety participants had complete information about
their parents’ origin. Of these, 98% were of Andean origin and 2%
were mestizo. No black or white people participated. Eighty-fourTable 2
Characteristics of the study populations by province
Province Participants HTLV-
1-positive
Median
age,a
years
Median age
at ﬁrst
sexual
intercourse
Females
(%)
Numbe
lifetim
sexual
partne
Parinacochas 79 8 (10%) 49 18 60 (76%) 2 
Vilcashuaman 154 3 (2%) 39 18 100 (65%) 1 
Cangallo 164 0 38 18 113 (69%) 1 
Total 397 11 41 18 273 (69%) 1 
HTLV-1, human T-lymphotropic virus type 1.
a Signiﬁcant.
b Where information was available.percent of the participants were born in the province where they
were enrolled and 94% were born in Ayacucho. However, the
number of people born outside the province where they were
enrolled appeared higher in Vilcashuaman (16%) and Cangallo
(19%) than in Parinacochas (9%). Seventy-one percent were
married or were in a stable monogamous relationship; 18% were
single, 3% were separated or divorced, and 8% were widowed.
Ninety-nine percent were born via vaginal delivery.
None of the participants reported being a sex worker. None of
the men for whom the information was available had sex with
other men. There was no difference in the median age at ﬁrst
sexual intercourse between men and women, or among provinces.
The median number of sex partners was different by gender
(Mann–Whitney, p < 0.001): one for women (interquartile range
(IQR) 1–2) and two for men (IQR 1–5). The number of sexual
partners was different among provinces (Kruskal–Wallis, p = 0.01).
The median number of partners in Parinacochas was two (IQR 1–2)
and in Vilcashuaman and Cangallo was one (IQR 1–6). Of the 322
sexually active participants, 42% reported the use of a contracep-
tive method, with 34% of them saying that they used condoms. The
rate of condom use was not different among provinces. None of the
participants used intravenous drugs. One percent had a tattoo.
Eighteen out of 394 (5%) had received a blood transfusion, and 83%
of them were women. Indications for transfusion were mostly
gynecological (cesarean section, post-partum or post-abortion,
hysterectomy, vaginal prolapse, or molar pregnancy). Eighty-six
out of 394 (22%) participants had a history of surgery, and 81% of
them were women. Twenty-four out of 346 (7%) knew that they
had been breastfed by someone other than their mother. Out ofr
e
rsa
History of
transfusion
(%)
History of
surgery (%)
Number of
participants
who breastfedb
% Participants by breastfeed-
ing timeb
>2 years 1–2 years <1 year
3 (4%) 15 (19%) 76/77 (99%) 39% 56% 5%
6(4%) 30 (19%) 146/149 (98%) 57% 36% 7%
9 (5.5%) 41 (25%) 159/160 (99%) 57% 36% 7%
18 (5%) 86 (22%) 381/386 (99%) 53% 40% 6%
Table 3
HTLV-1 frequency by town
Province Town Participants HTLV-1-positive
Parinacochas A 28 1 (4%)
B 14 3 (21%)
C 35 4 (11%)
Vilcashuaman D 154 3 (2%)a
Cangallo E 164 0
Total 397 11
HTLV-1, human T-lymphotropic virus type 1.
a One of them was the only male HTLV-1-positive.
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Of these women, 72% (26/36) were related to the infant. The main
reasons for breastfeeding another woman’s child were the absence
of the biological mother because of work, disease, or death,
‘insufﬁcient milk’ in the biological mother, and because they were
taking care of the child.
Two ELISAs were done in 99% of the participants. Three hundred
eleven samples were tested with both commercial kits: Murex
ELISA and Ortho ELISA. Eighty-ﬁve samples were tested twice with
the Murex ELISA. Only one sample was tested once with the Ortho
ELISA, because it was of insufﬁcient size for further testing. Results
were discordant for four samples (one ELISA positive and the other
one negative). None of these samples was positive by conﬁrmatory
test. Only samples with two positive ELISA results were positive by
the conﬁrmatory tests.
Eleven participants (2.8%) were found to have HTLV-1. The
frequencies of HTLV-1-positive results by province were: 0% (0/164)
in Cangallo, 2% (3/154) in Vilcashuaman, and 10% (8/79) overall in
Parinacochas (Table 3). All cases were found in participants older
than 18 years of age. In Parinacochas, the frequencies of HTLV-1 by
town were 4% (1/28), 21% (3/14), and 11% (4/35). No cases of HTLV-2
were found. One result was indeterminate using INNO-LIA but
HTLV-negative using Western blot. We found no signiﬁcant
associations between HTLV-1 infection and demographic charac-
teristics or possible risk factors (Table 4).
Two women with HTLV-1 infection had problems walking and
one was diagnosed with HAM/TSP. She was 87 years old and had
been born in Parinacochas. Six of the 11 participants with HTLV-1
infection had a relative with problems walking. Three of them had
a description compatible with spastic paraparesis. HTLV-1 was
associated with a higher probability of having a relative with
walking difﬁculties (Chi-square, p = 0.007).Table 4
Factors associated with HTLV-1 infection
Risk factors Status 
HTLV-1-p
Female gendera 10/11 
Age, years, median (IQR)b 56 (31–6
Age at ﬁrst sexual intercourse, years, median (IQR)b 17 (15.5–
Number of sexual partners, median (IQR) 1 (1–2) 
Breastfeedinga 11/11 
Tattoosa 0/11 
Transfusiona 1/11 
Surgeriesa 3/11 
IV usea 2/11 
Vaginal deliverya 11/11 
Hepatitis/jaundice history 0/10 
HIV-positive 0 
History of STDs 4/10 
Family member with
walking difﬁculties
6/11 
HTLV-1, human T-lymphotropic virus type 1; IQR, interquartile range; IV, intravenous;
a Chi-square test.
b Rank sum test.4. Discussion
In this study we investigated the frequency of HTLV-1 infection
and searched for possible risk factors in a Quechua rural population
of Ayacucho, a region in the southern Andes of Peru. Our results
showed HTLV-1 infection frequencies of at least 2% in four out of
ﬁve communities, which indicates that a high prevalence is very
likely to occur in most of this area.
We observed differences in the frequencies of HTLV-1 among
the ﬁve communities studied: whereas it exceeded 2% in the three
communities in Parinacochas, no cases of HTLV-1 infection were
found in Cangallo. Four characteristics among the studied
communities could account for a real difference in the frequencies
of HTLV-1 infection: age, sex, relative isolation, and percentage of
participants born elsewhere. The communities with higher
frequencies of HTLV-1 infection were the smaller ones (less than
500 inhabitants), with limited access by public transportation
services and a poor road network. This relative isolation may
account for the limited population admixture and a certain degree
of endogamy, which, combined with other factors, may contribute
to the perpetuation of HTLV-1. The participants in Parinacochas
tended to be older than those in Cangallo by almost 10 years. HTLV-
1 prevalence increases with age, which has been reported
consistently in different countries, including Peru.9,10,13 This
observation can be explained by the birth cohort effect21,22 and
by a lifetime cumulative effect of the risk of transmission through
sexual intercourse or blood/needle exchange. The frequency of
women was also higher among the participants enrolled in
Parinacochas. HTLV-1 is more prevalent in women worldwide, as a
result of more effective sexual transmission from men to women,
and, before the implementation of HTLV-1 screening of candidate
blood donors, by a potentially higher exposure to transfusion-
transmitted HTLV-1 in women for obstetric reasons. It is likely that
exposure to transfusion-transmitted HTLV-1 will be higher in
women with a high parity index; in fact, in this study we observed
that most episodes of blood transfusion were secondary to
gynecological and obstetric reasons. Parinacochas also had the
lowest number of participants born elsewhere. Immigration of
people from non-endemic HTLV-1 areas could account for a
decrease in the rate of carriers22,23 and in the number of horizontal
sexual transmissions in these populations.
In contrast, the conditions of poverty (around 80%) and the rate
of illiteracy (twice the national average) were similar in all the
studied communities. Epidemiological studies in other countriesp-Value
ositive HTLV-1-negative
263/386 0.11
8) 40 (30–57) 0.06
19) 18 (16–20) 0.33
1 (1–2) 0.55
370/375 0.7
4/370 0.73
17/383 0.47
83/383 0.66
51/377 0.66
377/379 0.81
9/369 0.61
0
116/360 0.6
77/376 0.007
 STD, sexually transmitted disease.
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socioeconomic status and low educational level.24–26We also need
to consider that differences in HTLV-1 frequencies could have been
obscured by aspects of the study design. With regard to the
absence of cases with HTLV-1 infection in Cangallo, the health
center also provided care to people from the surrounding rural
communities; therefore, the proportion of the local population
included could have been lower than the one we intended, and
could potentially have resulted in an insufﬁcient sample size for a
low prevalence rate.
This is the ﬁrst study done in small Andean rural communities
in Ayacucho. Few studies have been done so far in the Quechua
population of the southern Andes. One study in Quillabamba,
Cuzco, found a 2.3% frequency of HTLV-1 among healthy low-risk
pregnant women.9 Quillabamba is a much larger city (26 000
inhabitants according to the 2007 National Census). In contrast to
our study, in Quillabamba HTLV-1 was more frequent in sex
workers, both homosexual and bisexual, and among people with a
history of sexually transmitted diseases. In other investigations
mainly conducted in more developed areas of large northern cities
of Ayacucho (Figure 1), HTLV-1 was reported in 0.5% of healthy
pregnant women.10,11 These cities, the capitals of provinces, have
larger populations, better socioeconomic conditions, and probably
different population dynamics.
The assessment of risk factors for HTLV-1 infection was limited
by the small number of HTLV-1-positive subjects and the fact that
these factors were self-reported, which could introduce a social
desirability bias (e.g., questions addressing sexual behavior).
Nonetheless, some valuable information was collected that might
explain the high HTLV-1 frequencies observed in some of the
studied communities, particularly with regard to breastfeeding
habits.
There is a clear association between the duration of breastfeed-
ing and the risk of HTLV-1 transmission,27 as has been reported in
many countries including Peru.27–29 In the present study, more
than half of the participants reported having been breastfed for
more than 2 years, which could have contributed to the endemicity
of HTLV-1 infection. The efﬁcacy of vertical transmission of HTLV-1
has also been associated with human leukocyte antigen (HLA)
concordance between mother and infant.30 HLA concordance may
be more frequent in isolated populations, therefore increasing the
risk of infection in communities like those reported here.
Surrogate breastfeeding has been associated with HIV infec-
tion31 and might be a risk factor for HTLV-1 infection not yet
reported in these communities. Surprisingly, 7% of the inter-
viewees knew that they had been breastfed by another woman,
most commonly by somebody else in the family. If HTLV-1 is
present in a family, being breastfed by more than one family
member may increase the infant’s risk of acquiring HTLV-1. On the
other hand, surrogate breastfeeding may also represent a way of
introducing HTLV-1 into non-infected families, and thereby favor
its persistence in the community.
No intravenous illegal drug users or sex workers were identiﬁed
in the communities studied. In addition, no men reported having
had sex with men. The number of lifetime sex partners was also
low, especially among women. However, it is important to point
out that the number of lifetime sex partners was higher in
Parinacochas, which may also have contributed to an increased risk
for the infection.
The association with HIV infection was not assessed in this
study. This could be seen as a limitation. Nevertheless, HIV
infection is relatively uncommon in Peru. A recent study32 reported
a prevalence of HIV infection of 0.5% among female sex workers,
and 0.5% among men and 0.1% among women in the general
population. The prevalence of HTLV-1 infection in that same study
was 0.3%, but unfortunately the authors did not specify the rate ofco-infection. Another study estimated that 84% of new cases were
concentrated in higher risk populations, such as men who have sex
with men and people who have casual heterosexual sex.33 As
previously discussed, the population that we studied did not report
high-risk sexual behavior. Based on the latest report of the Ministry
of Health of Peru,34 1243 new cases of HIV infection were reported
in the country during the ﬁrst half of 2013. Of these, 562 (45%)
were reported in Lima and three (0.2%) in Ayacucho. Also, the
cumulative incidence of HIV infection between 1983 and 2012 was
280 per 100 000 people for Lima and 16 per 100 000 people for
Ayacucho.34 This probably reﬂects a clustering of HIV infection in
urban areas, although more studies are needed to determine the
true prevalence of HIV infection in rural areas, where access to
health services is more limited.
Taken together, our ﬁndings are compatible with the hypothe-
sis that postnatal infection by breastfeeding may play a key role in
the transmission of HTLV-1 in the studied Andean population. If
proven, this would advocate for the adoption of prevention
strategies. The prevention policies in place in Japan, based on
prenatal screening of HTLV-1, along with counseling of the mother
and bottle feeding, have successfully reduced the prevalence of
HTLV-1 and related diseases in the population.3 However, the
implementation of policies with similar goals would face
additional challenges in Andean communities. Here, malnutrition
and infectious diseases remain the main causes of infant mortality
and morbidity, not to mention that breastfeeding, particularly in
rural areas, also impacts on birth spacing thus mitigating the rates
of infant mortality, stunting, and malnutrition.35–37 In view that in
previous studies3,27,28,38 most of the breastfeeding-related trans-
mission occurred in infants who had been breastfed for 6 or more
months, an alternative to consider would be a restriction of
breastfeeding to 6 months to 1 year in women with HTLV-1. This
measure should be actively linked with efforts to improve overall
infant nutrition,35 ensuring access to clean drinking water for these
populations,39 and promoting access to adequate birth control.
Interestingly, in this series the only factor associated with
HTLV-1 infection was having a relative with walking problems. In
the provinces where we found HTLV-1, we observed a case of HAM/
TSP and another two of spastic paraparesis in men, among persons
who declined to participate in the study. This observation raises
the question of whether undiagnosed clusters of HAM/TSP could
underlie the high rate of lower-limb disability not related to polio
reported in this area in the 1993 National Census. Familial and
ethnic clusters of HAM/TSP, described in other parts of the world,
such as Zaire,40 Brazil,41 and Argentina,42 suggest a genetic or
environmental predisposition to this disease. Interestingly, in the
report of 165 Peruvian cases of HAM/TSP, Andean origin, deﬁned as
we did, was associated with the disease.16 No studies of HAM/TPS
have been done in the Peruvian Andes; such studies could provide
evidence of the natural history of the disease in the Quechua
population.
This is the ﬁrst study done in a Quechua rural general
population in Peru that not only conﬁrms the presence of HTLV-
1 infection, but also suggests that it may be very frequent in some
communities. However, we should state that the sample was small
with regard to the number of enrolled individuals, and was also
non-randomly selected. On one hand, the remoteness of the
communities precluded random sampling, but, on the other, we
selected provinces for this study amongst those with the highest
rates of lower-limb disability according to the Peruvian National
Census of 1993 (the last one that reported such information). Even
if our ﬁndings support the initial hypothesis that such a situation
could in fact be a harbinger of the potential presence of HTLV-1 in
these areas, it also implies the need for additional studies to
determine the prevalence of this infection in the region and the risk
factors associated with it. Furthermore, HTLV-1 seems to manifest
F. Ita et al. / International Journal of Infectious Diseases 19 (2014) 46–5252itself directly according to the affected population and its location.
The morbidity associated with HTLV-1 infection in the Quechua
population has not yet been determined and further studies are
needed to quantify the consequences of this disease.
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